Single-chain antibody fragments: Purification methodologies
- Autores
- Pellegrini Malpiedi, Luciana; Diaz, César A.; Nerli, Bibiana Beatriz; Pessoa, Adalberto
- Año de publicación
- 2013
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- At present, single-chain variable fragments (scFv) of antibodies are considered one of the most important tools in human therapies. Wide applications of antibodies are being exploited in different medical, pharmaceutical and research areas. These molecules maintain the same binding functionality that full length antibodies but possess several advantageous features as quickness to penetrate the tissues, easy manipulation, fast elimination of their immunocomplex and the possibility of being produced in simple expression systems like bacteria and yeast. The increasing demand in antibody based methodologies is driving advances in the production and purification of genetically engineered antibodies and antibody fragments. While advances in expression systems allow the production of high titers of antibodies, there exist some limits imposed by the downstream methodologies which are not efficient enough to ensure their industrialization. The main aim of this review is to highlight the principal characteristics of single-chain variable fragments of antibodies addressing advances and perspectives on scFv purification.
Fil: Pellegrini Malpiedi, Luciana. Universidade de Sao Paulo; Brasil. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Diaz, César A.. Universidade de Sao Paulo; Brasil
Fil: Nerli, Bibiana Beatriz. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Pessoa, Adalberto. Universidade de Sao Paulo; Brasil - Materia
-
Immunoglobulin
Single-Chain Variable Fragment
First Capture
Platform Methodology - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/21592
Ver los metadatos del registro completo
id |
CONICETDig_f14034f0667890112e494ea004e9ea40 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/21592 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Single-chain antibody fragments: Purification methodologiesPellegrini Malpiedi, LucianaDiaz, César A.Nerli, Bibiana BeatrizPessoa, AdalbertoImmunoglobulinSingle-Chain Variable FragmentFirst CapturePlatform Methodologyhttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1At present, single-chain variable fragments (scFv) of antibodies are considered one of the most important tools in human therapies. Wide applications of antibodies are being exploited in different medical, pharmaceutical and research areas. These molecules maintain the same binding functionality that full length antibodies but possess several advantageous features as quickness to penetrate the tissues, easy manipulation, fast elimination of their immunocomplex and the possibility of being produced in simple expression systems like bacteria and yeast. The increasing demand in antibody based methodologies is driving advances in the production and purification of genetically engineered antibodies and antibody fragments. While advances in expression systems allow the production of high titers of antibodies, there exist some limits imposed by the downstream methodologies which are not efficient enough to ensure their industrialization. The main aim of this review is to highlight the principal characteristics of single-chain variable fragments of antibodies addressing advances and perspectives on scFv purification.Fil: Pellegrini Malpiedi, Luciana. Universidade de Sao Paulo; Brasil. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Diaz, César A.. Universidade de Sao Paulo; BrasilFil: Nerli, Bibiana Beatriz. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Pessoa, Adalberto. Universidade de Sao Paulo; BrasilElsevier2013-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/21592Pellegrini Malpiedi, Luciana; Diaz, César A.; Nerli, Bibiana Beatriz; Pessoa, Adalberto; Single-chain antibody fragments: Purification methodologies; Elsevier; Process Biochemistry; 48; 8; 6-2013; 1242-12511359-5113CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.procbio.2013.06.008info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S135951131300278Xinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:53:32Zoai:ri.conicet.gov.ar:11336/21592instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:53:33.097CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Single-chain antibody fragments: Purification methodologies |
title |
Single-chain antibody fragments: Purification methodologies |
spellingShingle |
Single-chain antibody fragments: Purification methodologies Pellegrini Malpiedi, Luciana Immunoglobulin Single-Chain Variable Fragment First Capture Platform Methodology |
title_short |
Single-chain antibody fragments: Purification methodologies |
title_full |
Single-chain antibody fragments: Purification methodologies |
title_fullStr |
Single-chain antibody fragments: Purification methodologies |
title_full_unstemmed |
Single-chain antibody fragments: Purification methodologies |
title_sort |
Single-chain antibody fragments: Purification methodologies |
dc.creator.none.fl_str_mv |
Pellegrini Malpiedi, Luciana Diaz, César A. Nerli, Bibiana Beatriz Pessoa, Adalberto |
author |
Pellegrini Malpiedi, Luciana |
author_facet |
Pellegrini Malpiedi, Luciana Diaz, César A. Nerli, Bibiana Beatriz Pessoa, Adalberto |
author_role |
author |
author2 |
Diaz, César A. Nerli, Bibiana Beatriz Pessoa, Adalberto |
author2_role |
author author author |
dc.subject.none.fl_str_mv |
Immunoglobulin Single-Chain Variable Fragment First Capture Platform Methodology |
topic |
Immunoglobulin Single-Chain Variable Fragment First Capture Platform Methodology |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
At present, single-chain variable fragments (scFv) of antibodies are considered one of the most important tools in human therapies. Wide applications of antibodies are being exploited in different medical, pharmaceutical and research areas. These molecules maintain the same binding functionality that full length antibodies but possess several advantageous features as quickness to penetrate the tissues, easy manipulation, fast elimination of their immunocomplex and the possibility of being produced in simple expression systems like bacteria and yeast. The increasing demand in antibody based methodologies is driving advances in the production and purification of genetically engineered antibodies and antibody fragments. While advances in expression systems allow the production of high titers of antibodies, there exist some limits imposed by the downstream methodologies which are not efficient enough to ensure their industrialization. The main aim of this review is to highlight the principal characteristics of single-chain variable fragments of antibodies addressing advances and perspectives on scFv purification. Fil: Pellegrini Malpiedi, Luciana. Universidade de Sao Paulo; Brasil. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Diaz, César A.. Universidade de Sao Paulo; Brasil Fil: Nerli, Bibiana Beatriz. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Pessoa, Adalberto. Universidade de Sao Paulo; Brasil |
description |
At present, single-chain variable fragments (scFv) of antibodies are considered one of the most important tools in human therapies. Wide applications of antibodies are being exploited in different medical, pharmaceutical and research areas. These molecules maintain the same binding functionality that full length antibodies but possess several advantageous features as quickness to penetrate the tissues, easy manipulation, fast elimination of their immunocomplex and the possibility of being produced in simple expression systems like bacteria and yeast. The increasing demand in antibody based methodologies is driving advances in the production and purification of genetically engineered antibodies and antibody fragments. While advances in expression systems allow the production of high titers of antibodies, there exist some limits imposed by the downstream methodologies which are not efficient enough to ensure their industrialization. The main aim of this review is to highlight the principal characteristics of single-chain variable fragments of antibodies addressing advances and perspectives on scFv purification. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/21592 Pellegrini Malpiedi, Luciana; Diaz, César A.; Nerli, Bibiana Beatriz; Pessoa, Adalberto; Single-chain antibody fragments: Purification methodologies; Elsevier; Process Biochemistry; 48; 8; 6-2013; 1242-1251 1359-5113 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/21592 |
identifier_str_mv |
Pellegrini Malpiedi, Luciana; Diaz, César A.; Nerli, Bibiana Beatriz; Pessoa, Adalberto; Single-chain antibody fragments: Purification methodologies; Elsevier; Process Biochemistry; 48; 8; 6-2013; 1242-1251 1359-5113 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.procbio.2013.06.008 info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S135951131300278X |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613634403074048 |
score |
13.070432 |